Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
International Journal of Molecular Sciences|July 19, 2013
Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancerSara Alcorn, Amanda J Walker, Nishant Gandhi, et al.
The Prostate|March 10, 2018
Detectable end of radiation prostate specific antigen assists in identifying men with unfavorable intermediate-risk prostate cancer at high risk of distant recurrence and cancer-specific mortalityJonathan Hayman, Ryan Phillips, Di Chen, et al.
Molecular Cell|November 11, 2008
FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complexSpencer J Collis, Alberto Ciccia, Andrew J Deans, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2008
High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilitiesJohn Wong, Elwood Armour, Peter Kazanzides, et al.
F1000Research|October 6, 2023
Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patientsHannah Gagg, Sophie T Williams, Samantha Conroy, et al.
Expert Reviews in Molecular Medicine|October 3, 2022
Precision oncology using ex vivo technology: a step towards individualised cancer care?Sophie T Williams, Greg Wells, Samantha Conroy, et al.
Urology|August 28, 2019
Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate CancerLuke C Peng, Omar Y Mian, Pranav Lakshminarayanan, et al.
The Prostate|June 19, 2008
Radiotherapy augments the immune response to prostate cancer in a time-dependent mannerTimothy J Harris, Edward L Hipkiss, Scott Borzillary, et al.
Oncotarget|July 30, 2014
FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agentsAbhijit A Patil, Parag Sayal, Marie-Lise Depondt, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2016
Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive RadiationAmol K Narang, Carol Gergis, Scott P Robertson, et al.
Pageof 17